{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:22:50Z","timestamp":1795072970115,"version":"4.10.2"},"reference-count":30,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:p>Autoimmune lymphoproliferative syndrome (ALPS) is an inherited nonmalignant lymphoproliferative disorder characterized by heterozygous mutations within the first apoptosis signal receptor (FAS) signaling pathway. Defects in FAS-mediated apoptosis cause an expansion and accumulation of autoreactive CD4\u2212 and CD8\u2212 (double-negative) T cells, leading to cytopenias, splenomegaly, lymphadenopathy, autoimmune disorders, and a greatly increased lifetime risk of lymphoma. The differential diagnosis of ALPS includes infection, other inherited immunodeficiency disorders, primary and secondary autoimmune syndromes, and lymphoma. The most consistent pathologic feature is a florid paracortical expansion of double-negative T cells in lymph nodes. A presumptive clinical diagnosis can be made from symptoms and a constellation of laboratory test results. However, a definitive diagnosis requires ancillary testing and enables disease subclassification. Recognition of ALPS is critical, as treatment with immunosuppressive therapies can effectively reduce or ameliorate symptoms for most patients.<\/jats:p>","DOI":"10.5858\/arpa.2018-0190-rs","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T13:28:12Z","timestamp":1554730092000},"page":"245-251","source":"Crossref","is-referenced-by-count":79,"title":["Autoimmune Lymphoproliferative Syndrome: An Overview"],"prefix":"10.5858","volume":"144","author":[{"given":"Daniel R.","family":"Matson","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"issue":"2","key":"2020081300432579000_i1543-2165-144-2-245-b01","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"issue":"2","key":"2020081300432579000_i1543-2165-144-2-245-b02","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2009.07991.x","article-title":"Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)","volume":"148","author":"Teachey","year":"2010","journal-title":"Br J Haematol"},{"key":"2020081300432579000_i1543-2165-144-2-245-b03","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.12688\/f1000research.11545.1","article-title":"Autoimmune lymphoproliferative syndrome: more than a FAScinating disease","volume":"6","author":"Bride","year":"2017","journal-title":"F1000Res"},{"issue":"2","key":"2020081300432579000_i1543-2165-144-2-245-b04","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1172\/JCI115867","article-title":"A novel lymphoproliferative\/autoimmune syndrome resembling murine lpr\/gld disease","volume":"90","author":"Sneller","year":"1992","journal-title":"J Clin Invest"},{"issue":"14","key":"2020081300432579000_i1543-2165-144-2-245-b05","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2020081300432579000_i1543-2165-144-2-245-b06","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)65742-2","article-title":"Pathological findings in human autoimmune lymphoproliferative syndrome","volume":"153","author":"Lim","year":"1998","journal-title":"Am J Pathol"},{"key":"2020081300432579000_i1543-2165-144-2-245-b07","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1600-065X.2003.00051.x","article-title":"Activation-induced cell death in T cells","volume":"193","author":"Green","year":"2003","journal-title":"Immunol Rev"},{"issue":"2","key":"2020081300432579000_i1543-2165-144-2-245-b08","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood-2015-11-685024","article-title":"Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome","volume":"128","author":"V\u00f6lkl","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2020081300432579000_i1543-2165-144-2-245-b09","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/302333","article-title":"Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance","volume":"64","author":"Jackson","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2020081300432579000_i1543-2165-144-2-245-b10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood.V89.4.1341","article-title":"Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis","volume":"89","author":"Sneller","year":"1997","journal-title":"Blood"},{"issue":"5","key":"2020081300432579000_i1543-2165-144-2-245-b11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-3476(98)70102-7","article-title":"The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis","volume":"133","author":"Infante","year":"1998","journal-title":"J Pediatr"},{"issue":"5","key":"2020081300432579000_i1543-2165-144-2-245-b12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00467-003-1087-3","article-title":"Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis","volume":"18","author":"Kanegane","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"2020081300432579000_i1543-2165-144-2-245-b13","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1053\/gast.1997.v113.pm9322534","article-title":"Fas\/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis","volume":"113","author":"Pensati","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"2020081300432579000_i1543-2165-144-2-245-b14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ajo.2004.09.017","article-title":"Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome","volume":"139","author":"Lim","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2020081300432579000_i1543-2165-144-2-245-b15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"issue":"7","key":"2020081300432579000_i1543-2165-144-2-245-b16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.pas.0000157997.61177.08","article-title":"Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome","volume":"29","author":"Maric","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081300432579000_i1543-2165-144-2-245-b17","doi-asserted-by":"crossref","first-page":"e1440","DOI":"10.1542\/peds.2012-2748","article-title":"Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis","volume":"132","author":"Rudman Spergel","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"2020081300432579000_i1543-2165-144-2-245-b18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.2015.138081","article-title":"Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation","volume":"102","author":"Xie","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"2020081300432579000_i1543-2165-144-2-245-b19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2009.12.983","article-title":"Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome","volume":"125","author":"Caminha","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"2020081300432579000_i1543-2165-144-2-245-b20","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1182\/blood-2009-08-239525","article-title":"Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study","volume":"115","author":"Seif","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2020081300432579000_i1543-2165-144-2-245-b21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.clim.2007.08.010","article-title":"Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans' syndrome","volume":"125","author":"Sava\u015fan","year":"2007","journal-title":"Clin Immunol"},{"issue":"2","key":"2020081300432579000_i1543-2165-144-2-245-b22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2141.2005.05809.x","article-title":"Management of Evans syndrome","volume":"132","author":"Norton","year":"2006","journal-title":"Br J Haematol"},{"issue":"6","key":"2020081300432579000_i1543-2165-144-2-245-b23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/eci.13.30","article-title":"A review on guidelines for management and treatment of common variable immunodeficiency [quiz in Expert Rev Clin Immunol. 2013;9(6):575]","volume":"9","author":"Abolhassani","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"2020081300432579000_i1543-2165-144-2-245-b24","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1182\/blood-2010-07-295501","article-title":"Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis","volume":"117","author":"Niemela","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2020081300432579000_i1543-2165-144-2-245-b25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/10428190310001593166","article-title":"Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations","volume":"45","author":"Poppema","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"22","key":"2020081300432579000_i1543-2165-144-2-245-b26","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1182\/blood-2011-07-325217","article-title":"How I treat autoimmune lymphoproliferative syndrome","volume":"118","author":"Rao","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2020081300432579000_i1543-2165-144-2-245-b27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MPH.0b013e31802d7503","article-title":"Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome","volume":"28","author":"Kossiva","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"2020081300432579000_i1543-2165-144-2-245-b28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2141.2009.07715.x","article-title":"Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin","volume":"146","author":"Cooper","year":"2009","journal-title":"Br J Haematol"},{"issue":"13","key":"2020081300432579000_i1543-2165-144-2-245-b29","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","article-title":"Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations","volume":"123","author":"Price","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2020081300432579000_i1543-2165-144-2-245-b30","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.3324\/haematol.2016.153411","article-title":"Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome","volume":"102","author":"Klemann","year":"2017","journal-title":"Haematologica"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/2\/245\/2500788\/arpa_2018-0190-rs.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/2\/245\/2500788\/arpa_2018-0190-rs.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:13Z","timestamp":1764790813000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/144\/2\/article-p245.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,4,8]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2018-0190-rs","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]}}}